Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | ENGN | IMMX | ||
| Company | Urovant Sciences Ltd | Engene Therapeutics Inc | Immix Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 8.02 | 10.22 | ||
| High | 16.24 | 8.34 | 10.28 | ||
| Low | 16.21 | 7.69 | 9.69 | ||
| Latest | 16.24 | 7.99 | 9.85 | ||
| Change | +0.01 | -0.15 | -0.32 | ||
| % Change | +0.06% | -1.84% | -3.15% | ||
| Volume | 1,739,000 | 222,200 | 385,200 | ||
| 20-Day Average Volume | 143,510 | 263,500 | 712,975 | ||
| Previous Close | 16.23 | 8.14 | 10.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 7.49 | 9.44 | ||
| 20-Day Raw Stochastic | 87.10% | 69.29% | 73.15% | ||
| 20-Day Relative Strength | 65.56 | 51.01 | 54.98 | ||
| Weighted Alpha | +6.45 | +49.61 | +307.14 | ||
| Today's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 8% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -0.99% since 04/17/26 | -4.83% since 04/17/26 | ||
| Low | 16.20 on 03/24/21 | 7.66 on 04/20/26 | 9.55 on 04/21/26 | ||
| High | 16.25 on 03/25/21 | 8.85 on 04/23/26 | 10.35 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +15.80% since 03/24/26 | +14.94% since 03/24/26 | ||
| Low | 16.10 on 03/02/21 | 6.05 on 03/30/26 | 8.00 on 03/27/26 | ||
| High | 16.26 on 03/19/21 | 8.85 on 04/23/26 | 10.53 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -34.35% since 01/23/26 | +83.09% since 01/23/26 | ||
| Low | 16.03 on 12/30/20 | 6.05 on 03/30/26 | 5.07 on 01/26/26 | ||
| High | 16.26 on 03/19/21 | 12.21 on 01/26/26 | 11.61 on 03/17/26 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | -3.33% since 10/24/25 | +172.85% since 10/24/25 | ||
| Low | 7.15 on 11/02/20 | 5.72 on 11/07/25 | 2.85 on 11/06/25 | ||
| High | 16.26 on 03/19/21 | 12.25 on 01/23/26 | 11.61 on 03/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 535,210 | 522,168 | ||
| Shares Outstanding, K | 32,743 | 66,985 | 53,012 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -146,750,000 | -117,300,000 | -29,440,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -46,800,000 | -29,750,000 | -10,690,000 | ||
| 60-Month Beta | 2.35 | -0.06 | 0.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.44 on 03/09/26 | -0.28 on 03/25/26 | ||
| Latest Earnings Date | 06/17/21 | 06/11/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 12/24/14 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||